Acute Lymphoblastic Leukemia (ALL) is a fast-growing hematologic malignancy that originates in the bone marrow and results in the overproduction of immature lymphoid cells (lymphoblasts). While it most commonly affects c...
Acute myeloid leukemia, or AML, is an uncommon but serious form of cancer that starts in thebone marrow and quickly spreads to the blood. It’s a fast-moving condition that can becomelife-threatening without prompt treatm...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy originating from precursor plasmacytoid dendritic cells. Accounting for less than 1% of all hematologic cancers, BPDCN...
Chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML) are hematologic malignancies characterized by the clonal proliferation of abnormal white blood cells. While both diseases are chronic leukemias, they...
Diffuse Large B-Cell lymphoma, also known as DLBCL, is a type of cancer where B-cells, a type of white blood cell, become abnormal and spread throughout tissues and organs. DLBCL can often be fatal if left untreated due...
Multiple Myeloma (MM) is a rare, chronic cancer of the plasma cells—antibody-producing white blood cells found in the bone marrow. In MM, abnormal plasma cells multiply uncontrollably, displacing healthy marrow and relea...
Myelodysplastic Syndromes (MDS) are a group of uncommon blood disorders where the bone marrow does not produce enough healthy blood cells. This leads to low levels of red blood cells, white blood cells, and platelets. MD...
Cellular therapies have revolutionized the treatment landscape for hematologic and solid malignancies, offering highly targeted approaches that harness the immune system’s power. Two of the most promising modalities in t...
PCNSL is a form of non-Hodgkin lymphoma that originates within the central nervous system (CNS), including the brain, spinal cord, and eyes. Unlike other lymphomas that primarily involve lymph nodes, PCNSL is confined to...
